2[2]Chung R,Lai R,Wei P,et al.Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index[J].Blood,2007,110(4):1278～1782.
3[7]Conlan MG,Bast M,Armitage JO,et al.Bone marrow involvement by non-Hodgkin's lymphoma:the clinical significance of morphologic discordance between the lymph node and bone marrow[J].J Clin Oncol,1990,8:1163～1172.
4[10]Vadlamudi G,Lionetti KA,Greenberg S,et al.Leukemic phase of mantle cell lymphoma two case reports and review of the literature[J].Arch Pathol Lab Med,1996,120(1):35～40.
5[11]Maes B,Aehten R,Demunter A,et al.Evaluation of B cell lymphoid infiltrates in bone marrow biopsies by morphology,immunohistochemistry,and molecular analysis[J].J Clin Pathol,2000,53(11):835～840.
8Kari L,Loboda A,Nebozhyn M,et al.Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma[J].J Exp Med,2003,197(11):1477-1488.
9Khokhar MT,Brito-Babapulle V,Matutes E,et al.Matutes cytogenetic abnormalities in the leukemic phase of non-Hodgkin lymphoma[J].Cancer Genet Cytogenet,1995,83(1):18-24.
10Vadlamudi G,Lionetti KA,Greenberg S,et al.Leukemic phase of mantle cell lymphoma two case reports and review of the literature[J].Arch Pathol Lab Med,1996,120(1):35-40.
